BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22686208)

  • 1. Metabolomics as a key integrator for "omic" advancement of personalized medicine and future therapies.
    Eckhart AD; Beebe K; Milburn M
    Clin Transl Sci; 2012 Jun; 5(3):285-8. PubMed ID: 22686208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era.
    Tebani A; Abily-Donval L; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics toward personalized medicine.
    Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
    Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
    Frédérich M; Pirotte B; Fillet M; de Tullio P
    J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenomics of Vascular Disease: The Systematic Approach to the Combination Therapy.
    Han Y; Li L; Zhang Y; Yuan H; Ye L; Zhao J; Duan DD
    Curr Vasc Pharmacol; 2015; 13(4):433-40. PubMed ID: 25313004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.
    Sookoian S; Pirola CJ
    World J Gastroenterol; 2015 Jan; 21(3):711-25. PubMed ID: 25624707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond genomics: understanding exposotypes through metabolomics.
    Rattray NJW; Deziel NC; Wallach JD; Khan SA; Vasiliou V; Ioannidis JPA; Johnson CH
    Hum Genomics; 2018 Jan; 12(1):4. PubMed ID: 29373992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-platform 'multi-omic' profiling: unified mass spectrometry and computational workflows for integrative proteomics-metabolomics analysis.
    Blum BC; Mousavi F; Emili A
    Mol Omics; 2018 Oct; 14(5):307-319. PubMed ID: 30211418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.
    Würtz P; Kangas AJ; Soininen P; Lawlor DA; Davey Smith G; Ala-Korpela M
    Am J Epidemiol; 2017 Nov; 186(9):1084-1096. PubMed ID: 29106475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
    Marcinkiewicz-Siemion M; Ciborowski M; Kretowski A; Musial WJ; Kaminski KA
    Int J Cardiol; 2016 Sep; 219():156-63. PubMed ID: 27323342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests.
    Castelli FA; Rosati G; Moguet C; Fuentes C; Marrugo-Ramírez J; Lefebvre T; Volland H; Merkoçi A; Simon S; Fenaille F; Junot C
    Anal Bioanal Chem; 2022 Jan; 414(2):759-789. PubMed ID: 34432105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics through the lens of precision cardiovascular medicine.
    Lam SM; Wang Y; Li B; Du J; Shui G
    J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application.
    Zhan X; Long Y; Lu M
    J Proteomics; 2018 Sep; 188():30-40. PubMed ID: 28851587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics: moving to the clinic.
    Nordström A; Lewensohn R
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):4-17. PubMed ID: 19399626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved drug therapy: triangulating phenomics with genomics and metabolomics.
    Monte AA; Brocker C; Nebert DW; Gonzalez FJ; Thompson DC; Vasiliou V
    Hum Genomics; 2014 Sep; 8(1):16. PubMed ID: 25181945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine in Childhood Asthma: Omic Studies of Treatment Response.
    Perez-Garcia J; Herrera-Luis E; Lorenzo-Diaz F; González M; Sardón O; Villar J; Pino-Yanes M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel strategies for clinical investigation and biomarker discovery: a guide to applied metabolomics.
    Carneiro G; Radcenco AL; Evaristo J; Monnerat G
    Horm Mol Biol Clin Investig; 2019 Jan; 38(3):. PubMed ID: 30653466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diving through the "-omics": the case for deep phenotyping and systems epidemiology.
    Haring R; Wallaschofski H
    OMICS; 2012 May; 16(5):231-4. PubMed ID: 22320900
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.